The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Contemporary Cardiac Issues in Duchenne Muscular Dystrophy
Open accessAbstract
Duchenne muscular dystrophy (DMD) is an X-linked genetic disorder diagnosed in childhood. It affects ≈1 in every 5000 live male births (≈20 000 new cases worldwide each year).1,2 This results in a US prevalence of 1.3 to 1.8 per 10 000 males 5 to 24 years of age. DMD is caused by mutations in the gene encoding the dystrophin protein. The loss of dystrophin results in a cascade of events leading to progressive loss of muscle function. Without supportive care, young men with DMD typically die in their late teens and early 20s. Historically, the most common cause of death has been respiratory failure. However, with improved respiratory support, an increasingly important source of morbidity and mortality is cardiomyopathy leading to heart failure and arrhythmias.3,4 There are important differences in DMD cardiomyopathy compared with other types of pediatric dilated cardiomyopathy.5 DMD cardiomyopathy is similar to the cardiomyopathy seen in some forms of limb girdle muscular dystrophy and congenital muscular dystrophy. In particular, a shared cardiomyopathic process is seen in those disorders in which the primary mutation alters components that directly or indirectly interact with dystrophin. There is less left ventricular (LV) enlargement at diagnosis in DMD. Only 30% of boys with DMD have cardiac symptoms at diagnosis (far fewer than other dilated cardiomyopathy). DMD cardiomyopathy is less often treated at the time of diagnosis. However, treatment rates have increased over time. Finally, there is a higher mortality for DMD cardiomyopathy than for other dilated cardiomyopathies. The DMD Care Considerations published in 2010 addressed cardiac care recommendations based on minimal surveillance standards with echocardiography.6,7 However, echocardiography has known limitations in DMD patients.8 Since the 2010 publication of the DMD Care Considerations,6,7 there have been significant advances in the understanding …
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
Hunt, S. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.022 · Cited by 4,154
Eplerenone in patients with systolic heart failure and mild symptoms
Zannad, F., McMurray, J. J. V., Krum, H., van Veldhuisen, D. J., Swedberg, K., Shi, H., Vincent, J., Pocock, S. J., & Pitt, B. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009492 · Cited by 3,111 · cited 1×
“The Working Group concluded that medical management guidelines should extrapolate from newer animal model data and data from adult heart failure trials, including those that include the use of mineralocorticoid receptor antagonism.(34) The use of ACE inhibitors or ARBs has now become more mainstream in the DMD populat…”
WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.167586 · Cited by 2,251
Bushby, K., Finkel, R., Birnkrant, D. J., Case, L. E., Clemens, P. R., Cripe, L., Kaul, A., Kinnett, K., McDonald, C., Pandya, S., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70271-6 · Cited by 2,053
Self-citationPrevalence of Muscular Dystrophies: A Systematic Literature Review
Theadom, A., Rodrigues, M., Roxburgh, R., Balalla, S., Higgins, C., Bhattacharjee, R., Jones, K., Krishnamurthi, R., & Feigin, V. (2014) · Neuroepidemiology · doi:10.1159/000369343 · Cited by 2,046
Bushby, K., Finkel, R., Birnkrant, D. J., Case, L. E., Clemens, P. R., Cripe, L., Kaul, A., Kinnett, K., McDonald, C., Pandya, S., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70272-8 · Cited by 1,172
Self-citationEagle, M., Baudouin, S. V., Chandler, C., Giddings, D. R., Bullock, R., & Bushby, K. (2002) · Neuromuscular Disorders · doi:10.1016/s0960-8966(02)00140-2 · Cited by 1,009
Bleeker, G. B., Kaandorp, T. A. M., Lamb, H. J., Boersma, E., Steendijk, P., de Roos, A., van der Wall, E. E., Schalij, M. J., & Bax, J. J. (2006) · Circulation · doi:10.1161/circulationaha.105.543678 · Cited by 760
Tilson, M. D. (2005) · Circulation · doi:10.1161/circulationaha.105.553370 · Cited by 654
Carvedilol for Children and Adolescents With Heart Failure: A Randomized Controlled Trial
Shaddy, R. E., Boucek, M. M., Hsu, D. T., Boucek, R. J., Canter, C. E., Mahony, L., Ross, R. D., Pahl, E., Blume, E. D., Dodd, D. A., et al. (2007) · JAMA · doi:10.1001/jama.298.10.1171 · Cited by 570
Self-citationGlucocorticoid corticosteroids for Duchenne muscular dystrophy
Manzur, A., Kuntzer, T., Pike, M., & Swan, A. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003725.pub2 · Cited by 539
MAXWELL, M. P., HEARSE, D. J., & YELLON, D. M. (1987) · Cardiovascular Research · doi:10.1093/cvr/21.10.737 · Cited by 515
Duboc, D., Meune, C., Lerebours, G., Devaux, J., Vaksmann, G., & Bécane, H. M. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.09.078 · Cited by 437
Glucocorticoid corticosteroids for Duchenne muscular dystrophy
Manzur, A. Y., Kuntzer, T., Pike, M., & Swan, A. V. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003725.pub3 · Cited by 437
Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up
Duboc, D., Meune, C., Pierre, B., Wahbi, K., Eymard, B., Toutain, A., Berard, C., Vaksmann, G., Weber, S., & Bécane, H.-M. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.05.014 · Cited by 343
Chamberlain, J. S., Metzger, J., Reyes, M., Townsend, D., & Faulkner, J. A. (2007) · The FASEB Journal · doi:10.1096/fj.06-7353com · Cited by 330
Self-citationFlanigan, K. M., Dunn, D. M., von Niederhausern, A., Soltanzadeh, P., Gappmaier, E., Howard, M. T., Sampson, J. B., Mendell, J. R., Wall, C., King, W. M., et al. (2009) · Human Mutation · doi:10.1002/humu.21114 · Cited by 321
Dystrophic heart failure blocked by membrane sealant poloxamer
Yasuda, S., Townsend, D., Michele, D. E., Favre, E. G., Day, S. M., & Metzger, J. M. (2005) · Nature · doi:10.1038/nature03844 · Cited by 313
Self-citationBushby, K., Muntoni, F., & Bourke, J. P. (2003) · Neuromuscular Disorders · doi:10.1016/s0960-8966(02)00213-4 · Cited by 300
Feudtner, C. (2007) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2007.07.008 · Cited by 288
Genetic Predictors and Remodeling of Dilated Cardiomyopathy in Muscular Dystrophy
Jefferies, J. L., Eidem, B. W., Belmont, J. W., Craigen, W. J., Ware, S. M., Fernbach, S. D., Neish, S. R., Smith, E. O., & Towbin, J. A. (2005) · Circulation · doi:10.1161/circulationaha.104.528281 · Cited by 288
Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings
Quinlan, J. G., Hahn, H. S., Wong, B. L., Lorenz, J. N., Wenisch, A. S., & Levin, L. S. (2004) · Neuromuscular Disorders · doi:10.1016/j.nmd.2004.04.007 · Cited by 281
Raman, S. V., Hor, K. N., Mazur, W., Halnon, N. J., Kissel, J. T., He, X., Tran, T., Smart, S., McCarthy, B., Taylor, M. D., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70318-7 · Cited by 251
Self-citationCiafaloni, E., Fox, D. J., Pandya, S., Westfield, C. P., Puzhankara, S., Romitti, P. A., Mathews, K. D., Miller, T. M., Matthews, D. J., Miller, L. A., et al. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.02.007 · Cited by 245
Connuck, D. M., Sleeper, L. A., Colan, S. D., Cox, G. F., Towbin, J. A., Lowe, A. M., Wilkinson, J. D., Orav, E. J., Cuniberti, L., Salbert, B. A., et al. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.01.018 · Cited by 234
Cardiovascular Health Supervision for Individuals Affected by Duchenne or Becker Muscular Dystrophy
Surgery, S. O. C. A. C. (2005) · Pediatrics · doi:10.1542/peds.2005-2448 · Cited by 214
Schram, G., Fournier, A., Leduc, H., Dahdah, N., Therien, J., Vanasse, M., & Khairy, P. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.12.008 · Cited by 213
Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy
Mendell, J. R., & Lloyd‐Puryear, M. (2013) · Muscle & Nerve · doi:10.1002/mus.23810 · Cited by 202
The mdx mouse model as a surrogate forDuchenne muscular dystrophy
Partridge, T. A. (2013) · The FEBS Journal · doi:10.1111/febs.12267 · Cited by 187
Danialou, G., Comtois, A. S., Dudley, R., Karpati, G., Vincent, G., Des Rosiers, C., & Petrof, B. J. (2001) · The FASEB Journal · doi:10.1096/fj.01-0030fje · Cited by 185
Klymiuk, N., Blutke, A., Graf, A., Krause, S., Burkhardt, K., Wuensch, A., Krebs, S., Kessler, B., Zakhartchenko, V., Kurome, M., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt287 · Cited by 175
Viollet, L., Thrush, P. T., Flanigan, K. M., Mendell, J. R., & Allen, H. D. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.02.064 · Cited by 162
Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy
Adamo, C. M., Dai, D.-F., Percival, J. M., Minami, E., Willis, M. S., Patrucco, E., Froehner, S. C., & Beavo, J. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013077107 · Cited by 162
Hor, K. N., Taylor, M. D., Al‐Khalidi, H. R., Cripe, L. H., Raman, S. V., Jefferies, J. L., O’Donnell, R. E., Benson, D. W., & Mazur, W. M. (2013) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-15-107 · Cited by 157
Self-citationRafael‐Fortney, J. A., Chimanji, N. S., Schill, K. E., Martin, C. D., Murray, J. D., Ganguly, R., Stangland, J. E., Tran, T., Xu, Y., Canan, B. D., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.031716 · Cited by 138
Self-citationOgata, H., Ishikawa, Y., Ishikawa, Y., & Minami, R. (2008) · Journal of Cardiology · doi:10.1016/j.jjcc.2008.08.013 · Cited by 132
Steroid Therapy and Cardiac Function in Duchenne Muscular Dystrophy
Markham, L. W., Spicer, R., Khoury, P. R., Wong, B. L. Y., Mathews, K. D., & Cripe, L. H. (2005) · Pediatric Cardiology · doi:10.1007/s00246-005-0909-4 · Cited by 125
Self-citationHathout, Y., Marathi, R., Rayavarapu, S., Zhang, A., Brown, K. J., Seol, H., Gordish‐Dressman, H., Çırak, S., Bello, L., Nagaraju, K., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu366 · Cited by 123
Self-citationChetboul, V. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.09.007 · Cited by 122
Bostick, B., Yue, Y., Long, C., & Duan, D. (2007) · Circulation Research · doi:10.1161/circresaha.107.162982 · Cited by 120
Self-citationKhairallah, M., Khairallah, R. J., Young, M. E., Allen, B. G., Gillis, M., Danialou, G., Deschepper, C. F., Petrof, B. J., & Rosiers, C. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710595105 · Cited by 120
Beta-Blocker Therapy for Cardiac Dysfunction in Patients With Muscular Dystrophy
Kajimoto, H., Ishigaki, K., Okumura, K., Tomimatsu, H., Nakazawa, M., Saito, K., Ōsawa, M., & Nakanishi, T. (2006) · Circulation Journal · doi:10.1253/circj.70.991 · Cited by 117
New Approaches in the Therapy of Cardiomyopathy in Muscular Dystrophy
McNally, E. M. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.58.011706.144703 · Cited by 115
Self-citationTownsend, D., Turner, I. I., Yasuda, S., Martindale, J. J., Davis, J., Shillingford, M. S., Kornegay, J. N., & Metzger, J. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41329 · Cited by 111
Self-citationPDE5 inhibition alleviates functional muscle ischemia in boys with Duchenne muscular dystrophy
Nelson, M. D., Rader, F., Tang, X., Tavyev, J., Nelson, S. F., Miceli, M. C., Elashoff, R. M., Sweeney, H. L., & Victor, R. G. (2014) · Neurology · doi:10.1212/wnl.0000000000000498 · Cited by 107
Rouillon, J., Zocevic, A., Léger, T., Garcia, C., Camadro, J., Udd, B., Wong, B. L. Y., Servais, L., Voït, T., & Svinartchouk, F. (2014) · Neuromuscular Disorders · doi:10.1016/j.nmd.2014.03.012 · Cited by 102
Spurney, C. F., Shimizu, R., Morgenroth, L. P., Kolski, H., Gordish‐Dressman, H., Clemens, P. R., & the CINRG Investigators (2014) · Muscle & Nerve · doi:10.1002/mus.24163 · Cited by 101
Self-citationTadalafil Alleviates Muscle Ischemia in Patients with Becker Muscular Dystrophy
Martin, E. A., Barresi, R., Byrne, B. J., Tsimerinov, E. I., Scott, B. L., Walker, A. E., Gurudevan, S. V., Anene, F., Elashoff, R. M., Thomas, G. D., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004327 · Cited by 100
Predictive Value of Myocardial Delayed Enhancement in Duchenne Muscular Dystrophy
Menon, S. C., Etheridge, S. P., Liesemer, K. N., Williams, R. V., Bardsley, T. R., Heywood, M. C., & Puchalski, M. D. (2014) · Pediatric Cardiology · doi:10.1007/s00246-014-0929-z · Cited by 98
Fibronectin is a serum biomarker for D uchenne muscular dystrophy
Martin, F. C., Hiller, M., Spitali, P., Oonk, S., Dalebout, H., Palmblad, M., Chaouch, A., Guglieri, M., Straub, V. W., Lochmüller, H., et al. (2014) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201300072 · Cited by 97
Consequences of Disrupting the Dystrophin-Sarcoglycan Complex in Cardiac and Skeletal Myopathy
Heydemann, A., & McNally, E. M. (2007) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2006.12.002 · Cited by 86
Self-citationMora, M., Angelini, C. I., Bignami, F., Bodin, A.-M., Crimi, M., di Donato, J. H., Felice, A. E., Jaeger, C., Karcagi, V., Cam, Y. L., et al. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.272 · Cited by 85
Challenges and opportunities in dystrophin-deficient cardiomyopathy gene therapy
Duan, D. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl180 · Cited by 85
Self-citationSildenafil does not improve cardiomyopathy in D uchenne/ B ecker muscular dystrophy
Leung, D. G., Herzka, D. A., Thompson, W. R., He, B., Bibat, G., Tennekoon, G. I., Russell, S. D., Schuleri, K. H., Lardo, A. C., Kass, D. A., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24214 · Cited by 83
Self-citationTreatment of dystrophin cardiomyopathies
Finsterer, J., & Cripe, L. H. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.213 · Cited by 79
Self-citationCarvedilol can Prevent Cardiac Events in Duchenne Muscular Dystrophy
Matsumura, T., Tamura, T., Kuru, S., Kikuchi, Y., & Kawai, M. (2010) · Internal Medicine · doi:10.2169/internalmedicine.49.3259 · Cited by 79
Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice
Li, D., Long, C., Yue, Y., & Duan, D. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp015 · Cited by 73
Self-citationHainsey, T. A., Senapati, S., Kuhn, D. E., & Rafael, J. A. (2003) · Neuromuscular Disorders · doi:10.1016/s0960-8966(02)00286-9 · Cited by 71
Novel Approaches to Corticosteroid Treatment in Duchenne Muscular Dystrophy
Hoffman, E. P., Reeves, E. K. M., Damsker, J. M., Nagaraju, K., McCall, J. M., Connor, E. M., & Bushby, K. (2012) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2012.08.003 · Cited by 64
Self-citationJanssen, P. M. L., Murray, J. D., Schill, K. E., Rastogi, N., Schultz, E. J., Tran, T., Raman, S. V., & Rafael‐Fortney, J. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088360 · Cited by 59
Self-citationHolloway, S., Wilcox, D. E., Wilcox, A. J., Dean, J., Berg, J. N., Goudie, D. R., Denvir, M. A., & Porteous, M. E. (2007) · Heart · doi:10.1136/hrt.2007.125948 · Cited by 50
Fine, D. M., Shin, J., Yue, Y., Volkmann, D. H., Leach, S. B., Smith, B. F., McIntosh, M., & Duan, D. (2011) · Neuromuscular Disorders · doi:10.1016/j.nmd.2011.03.010 · Cited by 49
Self-citationEffect of sildenafil on skeletal and cardiac muscle in B ecker muscular dystrophy
Witting, N., Kruuse, C. R., Nyhuus, B., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24216 · Cited by 43
Hollinger, K., Yang, C. X., Montz, R. E., Nonneman, D., Ross, J. W., & Selsby, J. T. (2013) · The FASEB Journal · doi:10.1096/fj.13-241141 · Cited by 37
Geller, G., Harrison, K. L., & Rushton, C. H. (2012) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e318267c62d · Cited by 20
Cited by
Birnkrant, D. J., Bushby, K., Bann, C. M., Apkon, S. D., Blackwell, A., Brumbaugh, D., Case, L. E., Clemens, P. R., Hadjiyannakis, S., Pandya, S., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30024-3 · Cited by 1,370
Self-citationDuan, D., Goemans, N., Takeda, S., Mercuri, E., & Aartsma-Rus, A. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00248-3 · Cited by 1,312
Self-citationBirnkrant, D. J., Bushby, K., Bann, C. M., Alman, B. A., Apkon, S. D., Blackwell, A., Case, L. E., Cripe, L., Hadjiyannakis, S., Olson, A. K., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30025-5 · Cited by 1,167
Self-citationSystemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy
Duan, D. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.07.011 · Cited by 489
Self-citationFeingold, B., Mahle, W. T., Auerbach, S., Clemens, P., Domenighetti, A. A., Jefferies, J. L., Judge, D. P., Lal, A. K., Markham, L. W., Parks, W. J., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000526 · Cited by 306
Self-citation
Metadata
- Authors
- McNally, E. M., Kaltman, J. R., Benson, D. W., Canter, C. E., Cripe, L. H., Duan, D., Finder, J. D., Groh, W. J., Hoffman, E. P., Judge, D. P., Kertesz, N., Kinnett, K., Kirsch, R., Metzger, J. M., Pearson, G. D., Rafael-Fortney, J. A., Raman, S. V., Spurney, C. F., Targum, S. L., Wagner, K. R., & Markham, L. W.
- Venue
- Circulation
- Published
- 2015-05-05
- Volume
- 131
- Issue
- 18
- Pages
- 1590-1598
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2131791299
- Cited by
- 326
- References
- 65
- FWCI
- 20.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.